Patent · US Active

Engineered DNA binding proteins

US12083188B2 · kind B2 · utility

0Cited by

63References

20Claims

0Family size

Assignee

Encoded Therapeutics, Inc. · US

Inventors

Stephanie TAGLIATELA · San Francisco, US
Anne TANENHAUS · Brisbane, US
Kartik Ramamoorthi · South San Francisco, US
Andrew YOUNG · South San Francisco, US
David OBERKOFLER · San Francisco, US

Key dates

Filing date	May 28, 2020
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Nov 23, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/008
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions and methods of use thereof comprising a non-naturally occurring DNA binding protein that modulates expression of an endogenous gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.